Total Brain Limited Logo

Total Brain Limited

TTB.AX

(1.2)
Stock Price

0,00 AUD

-100.6% ROA

-104.7% ROE

-0.01x PER

Market Cap.

267.442,00 AUD

11.84% DER

0% Yield

-175.64% NPM

Total Brain Limited Stock Analysis

Total Brain Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Total Brain Limited Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0.02x), the stock offers substantial upside potential at a bargain price.

2 DER

The stock has a minimal amount of debt (12%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

3 Graham Number

The company's Graham number indicates that it is undervalued compared to its stock price, suggesting a potentially favorable investment opportunity.

4 ROE

Negative ROE (-104.7%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

5 ROA

The stock's ROA (-100.6%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

6 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

7 Net Profit Growth

This company's net profit has remained flat over the past five years, suggesting a lack of growth and making it a less attractive investment opportunity.

8 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

9 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

10 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

11 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (0) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

Total Brain Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Total Brain Limited Technical Stock Analysis
# Analysis Recommendation

Total Brain Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Total Brain Limited Revenue
Year Revenue Growth
2000 0
2001 0 0%
2002 246.188 100%
2003 505.459 51.29%
2004 1.376.040 63.27%
2005 1.316.519 -4.52%
2006 2.386.393 44.83%
2007 3.249.020 26.55%
2008 6.318.696 48.58%
2009 7.618.121 17.06%
2010 5.534.104 -37.66%
2011 3.719.554 -48.78%
2012 3.225.663 -15.31%
2013 2.531.438 -27.42%
2014 2.637.973 4.04%
2015 2.910.157 9.35%
2016 2.400.949 -21.21%
2017 2.608.990 7.97%
2018 2.602.137 -0.26%
2019 3.877.529 32.89%
2020 3.877.529 0%
2021 8.415.593 53.92%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Total Brain Limited Research and Development Expenses
Year Research and Development Expenses Growth
2000 0
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Total Brain Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2000 30.308
2001 845.597 96.42%
2002 1.113.142 24.04%
2003 1.517.180 26.63%
2004 1.605.822 5.52%
2005 1.997.345 19.6%
2006 2.255.844 11.46%
2007 3.425.628 34.15%
2008 3.877.249 11.65%
2009 3.422.724 -13.28%
2010 2.903.862 -17.87%
2011 2.860.831 -1.5%
2012 2.139.675 -33.7%
2013 2.358.597 9.28%
2014 2.997.095 21.3%
2015 3.155.523 5.02%
2016 2.935.968 -7.48%
2017 5.119.347 42.65%
2018 7.260.380 29.49%
2019 8.325.002 12.79%
2020 8.029.898 -3.68%
2021 13.144.449 38.91%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Total Brain Limited EBITDA
Year EBITDA Growth
2000 -60.310
2001 -2.319.235 97.4%
2002 -2.682.210 13.53%
2003 -1.994.220 -34.5%
2004 -2.706.075 26.31%
2005 -1.684.449 -60.65%
2006 -1.706.291 1.28%
2007 -1.646.697 -3.62%
2008 4.268.921 138.57%
2009 2.784.608 -53.3%
2010 371.032 -650.5%
2011 996.822 62.78%
2012 -188.837 627.87%
2013 -1.099.480 82.82%
2014 -1.541.809 28.69%
2015 -2.437.894 36.76%
2016 -8.777.077 72.22%
2017 -23.336.900 62.39%
2018 -6.769.265 -244.75%
2019 -7.430.215 8.9%
2020 -7.416.309 -0.19%
2021 -5.491.124 -35.06%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Total Brain Limited Gross Profit
Year Gross Profit Growth
2000 0
2001 -198.684 100%
2002 142.509 239.42%
2003 275.236 48.22%
2004 726.303 62.1%
2005 866.068 16.14%
2006 1.542.814 43.86%
2007 2.725.728 43.4%
2008 5.819.391 53.16%
2009 7.240.750 19.63%
2010 5.243.606 -38.09%
2011 3.312.269 -58.31%
2012 2.884.244 -14.84%
2013 2.332.027 -23.68%
2014 2.172.390 -7.35%
2015 2.185.150 0.58%
2016 2.229.512 1.99%
2017 2.486.783 10.35%
2018 2.283.552 -8.9%
2019 3.233.061 29.37%
2020 3.233.061 0%
2021 7.649.061 57.73%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Total Brain Limited Net Profit
Year Net Profit Growth
2000 -30.155
2001 -1.351.996 97.77%
2002 -1.326.032 -1.96%
2003 0 0%
2004 -1.122.980 100%
2005 -1.438.283 21.92%
2006 -1.454.578 1.12%
2007 -1.505.014 3.35%
2008 4.195.463 135.87%
2009 2.213.505 -89.54%
2010 269.487 -721.38%
2011 388.425 30.62%
2012 -1.459.681 126.61%
2013 -1.997.880 26.94%
2014 -2.595.316 23.02%
2015 -4.025.097 35.52%
2016 -9.868.954 59.21%
2017 -23.101.340 57.28%
2018 -8.527.512 -170.9%
2019 -7.632.816 -11.72%
2020 -7.647.544 0.19%
2021 -14.780.842 48.26%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Total Brain Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2000 0
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 -1 0%
2017 -1 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Total Brain Limited Free Cashflow
Year Free Cashflow Growth
2000 -30.155
2001 -2.102.380 98.57%
2002 -801.461 -162.32%
2003 -1.389.125 42.3%
2004 -1.385.633 -0.25%
2005 -2.184.466 36.57%
2006 15.574.580 114.03%
2007 -1.637.327 1051.22%
2008 -3.844.143 57.41%
2009 -4.960.502 22.5%
2010 -6.902.670 28.14%
2011 -7.498.446 7.95%
2012 -4.909.051 -52.75%
2013 -3.743.114 -31.15%
2014 -5.897.328 36.53%
2015 -4.277.671 -37.86%
2016 -2.247.434 -90.34%
2017 -5.619.244 60%
2018 -8.311.037 32.39%
2019 -8.732.455 4.83%
2020 -684.160 -1176.38%
2021 -17.881.874 96.17%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Total Brain Limited Operating Cashflow
Year Operating Cashflow Growth
2000 -30.155
2001 -1.454.021 97.93%
2002 0 0%
2003 -891.469 100%
2004 -862.334 -3.38%
2005 -1.521.416 43.32%
2006 16.619.314 109.15%
2007 -73.903 22588.01%
2008 1.074.338 106.88%
2009 -434.588 347.21%
2010 -2.764.659 84.28%
2011 -3.648.881 24.23%
2012 -2.080.328 -75.4%
2013 -1.428.952 -45.58%
2014 -3.131.832 54.37%
2015 -2.042.376 -53.34%
2016 -1.534.195 -33.12%
2017 -3.878.546 60.44%
2018 -5.647.392 31.32%
2019 -5.995.815 5.81%
2020 0 0%
2021 -13.640.501 100%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Total Brain Limited Capital Expenditure
Year Capital Expenditure Growth
2000 0
2001 648.359 100%
2002 801.461 19.1%
2003 497.656 -61.05%
2004 523.299 4.9%
2005 663.050 21.08%
2006 1.044.734 36.53%
2007 1.563.424 33.18%
2008 4.918.481 68.21%
2009 4.525.914 -8.67%
2010 4.138.011 -9.37%
2011 3.849.565 -7.49%
2012 2.828.723 -36.09%
2013 2.314.162 -22.24%
2014 2.765.496 16.32%
2015 2.235.295 -23.72%
2016 713.239 -213.4%
2017 1.740.698 59.03%
2018 2.663.645 34.65%
2019 2.736.640 2.67%
2020 684.160 -300%
2021 4.241.373 83.87%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Total Brain Limited Equity
Year Equity Growth
2000 6.344.256
2001 5.904.679 -7.44%
2002 6.828.647 13.53%
2003 9.142.027 25.3%
2004 8.019.054 -14%
2005 9.855.965 18.64%
2006 8.761.738 -12.49%
2007 7.343.958 -19.31%
2008 11.598.690 36.68%
2009 13.867.300 16.36%
2010 15.840.227 12.46%
2011 17.939.531 11.7%
2012 17.511.850 -2.44%
2013 17.227.845 -1.65%
2014 22.421.206 23.16%
2015 23.820.929 5.88%
2016 15.347.041 -55.22%
2017 21.781.655 29.54%
2018 20.219.900 -7.72%
2019 26.387.844 23.37%
2020 17.982.051 -46.75%
2021 10.252.351 -75.39%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Total Brain Limited Assets
Year Assets Growth
2000 6.344.256
2001 6.348.142 0.06%
2002 7.104.798 10.65%
2003 9.472.968 25%
2004 8.702.044 -8.86%
2005 10.471.240 16.9%
2006 28.532.506 63.3%
2007 26.640.515 -7.1%
2008 29.475.798 9.62%
2009 28.658.010 -2.85%
2010 29.187.233 1.81%
2011 35.874.637 18.64%
2012 33.315.436 -7.68%
2013 32.666.458 -1.99%
2014 38.051.296 14.15%
2015 36.923.851 -3.05%
2016 25.942.876 -42.33%
2017 22.854.675 -13.51%
2018 21.371.217 -6.94%
2019 29.406.400 27.32%
2020 24.088.295 -22.08%
2021 14.692.043 -63.95%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Total Brain Limited Liabilities
Year Liabilities Growth
2000 0
2001 443.463 100%
2002 276.151 -60.59%
2003 330.941 16.56%
2004 682.990 51.55%
2005 615.275 -11.01%
2006 19.770.768 96.89%
2007 19.296.557 -2.46%
2008 17.877.108 -7.94%
2009 14.790.710 -20.87%
2010 13.347.006 -10.82%
2011 17.935.106 25.58%
2012 15.803.586 -13.49%
2013 15.438.613 -2.36%
2014 15.630.090 1.23%
2015 13.102.922 -19.29%
2016 10.595.835 -23.66%
2017 1.073.020 -887.48%
2018 1.151.317 6.8%
2019 3.018.556 61.86%
2020 6.106.244 50.57%
2021 4.439.692 -37.54%

Total Brain Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.09
Net Income per Share
-0.15
Price to Earning Ratio
-0.01x
Price To Sales Ratio
0.03x
POCF Ratio
-0.01
PFCF Ratio
-0.01
Price to Book Ratio
0.02
EV to Sales
0.09
EV Over EBITDA
-0.14
EV to Operating CashFlow
-0.06
EV to FreeCashFlow
-0.04
Earnings Yield
-77.3
FreeCashFlow Yield
-66.86
Market Cap
0,00 Bil.
Enterprise Value
0,00 Bil.
Graham Number
0.61
Graham NetNet
-0.03

Income Statement Metrics

Net Income per Share
-0.15
Income Quality
0.92
ROE
-1.05
Return On Assets
-1.01
Return On Capital Employed
-0.65
Net Income per EBT
1.02
EBT Per Ebit
2.19
Ebit per Revenue
-0.79
Effective Tax Rate
-0.02

Margins

Sales, General, & Administrative to Revenue
1.56
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.91
Operating Profit Margin
-0.79
Pretax Profit Margin
-1.72
Net Profit Margin
-1.76

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.14
Free CashFlow per Share
-0.19
Capex to Operating CashFlow
0.31
Capex to Revenue
-0.5
Capex to Depreciation
-3.72
Return on Invested Capital
-0.59
Return on Tangible Assets
-1.01
Days Sales Outstanding
30.51
Days Payables Outstanding
90.01
Days of Inventory on Hand
0
Receivables Turnover
11.96
Payables Turnover
4.06
Inventory Turnover
0
Capex per Share
-0.04

Balance Sheet

Cash per Share
0,01
Book Value per Share
0,11
Tangible Book Value per Share
0.11
Shareholders Equity per Share
0.11
Interest Debt per Share
0.02
Debt to Equity
0.12
Debt to Assets
0.08
Net Debt to EBITDA
-0.09
Current Ratio
3.31
Tangible Asset Value
0,01 Bil.
Net Current Asset Value
0,01 Bil.
Invested Capital
0.12
Working Capital
0,01 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
109176.5
Debt to Market Cap
4.54

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Total Brain Limited Dividends
Year Dividends Growth

Total Brain Limited Profile

About Total Brain Limited

Total Brain Limited operates as an applied integrative neuroscience company in the United States and Australia. The company offers Total Brain, a mental health monitoring and support platform, that helps users to measure their brain capacities while managing the risk of common mental conditions. It serves companies, providers, affinity groups, and precision medicine sectors. The company was formerly known as Brain Resource Limited and changed its name to Total Brain Limited in December 2018. Total Brain Limited was incorporated in 2000 and is based in Surry Hills, Australia.

CEO
Mr. Matthew Mund
Employee
0
Address
15 Belvoir Street
Surry Hills, 2010

Total Brain Limited Executives & BODs

Total Brain Limited Executives & BODs
# Name Age
1 Ms. Donna Palmer
Chief Science Officer
70
2 Mr. Matt Resteghini
Chief Marketing Officer
70
3 Dr. Evian Gordon BSc (Hons), M.D., MBBCh, Ph.D.
Founder & Executive Chairman
70
4 Mr. Matthew Mund
MD, Chief Operating Officer, Interim Chief Executive Officer & Director
70
5 Mr. Louis Gagnon
Advisor
70
6 Mr. Marcel Legrand
Head of Revenue & Corporation Devel.
70
7 Mr. Nathan Jong C.A.
Joint Company Sec.
70
8 Mr. Simon Poidevin A.M., BSc (Hons), OAM
Pres of Australia & New Zealand
70
9 Mr. Phillip Hains B Bus, C.A., CA, M.B.A., MBA
Joint Company Sec.
70

Total Brain Limited Competitors